BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10235430)

  • 1. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease.
    Kohler HP; Futers TS; Grant PJ
    Thromb Haemost; 1999 Apr; 81(4):511-5. PubMed ID: 10235430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus.
    de Lange M; Andrew T; Snieder H; Ge D; Futers TS; Standeven K; Spector TD; Grant PJ; Ariëns RA
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1914-9. PubMed ID: 16763156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
    Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
    Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
    Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
    Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a common polymorphism in the factor XIII gene with myocardial infarction.
    Kohler HP; Stickland MH; Ossei-Gerning N; Carter A; Mikkola H; Grant PJ
    Thromb Haemost; 1998 Jan; 79(1):8-13. PubMed ID: 9459313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
    Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
    Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.
    Mills JD; Mansfield MW; Grant PJ
    Thromb Haemost; 2002 Mar; 87(3):409-14. PubMed ID: 11916071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FXII (46C-->T) polymorphism and in vivo generation of FXII activity--gene frequencies and relationship in patients with coronary artery disease.
    Kohler HP; Futers TS; Grant PJ
    Thromb Haemost; 1999 May; 81(5):745-7. PubMed ID: 10365748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.
    Warner D; Mansfield MW; Grant PJ
    Thromb Haemost; 2001 Mar; 85(3):408-11. PubMed ID: 11307805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction.
    Corbex M; Poirier O; Fumeron F; Betoulle D; Evans A; Ruidavets JB; Arveiler D; Luc G; Tiret L; Cambien F
    Genet Epidemiol; 2000 Jul; 19(1):64-80. PubMed ID: 10861897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage.
    López Ramírez Y; Vivenes M; Miller A; Pulido A; López Mora J; Arocha-Piñango CL; Marchi R
    Clin Chim Acta; 2006 Dec; 374(1-2):69-74. PubMed ID: 16844105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
    Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
    J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism.
    Attié-Castro FA; Zago MA; Lavinha J; Elion J; Rodriguez-Delfin L; Guerreiro JF; Franco RF
    Thromb Haemost; 2000 Oct; 84(4):601-3. PubMed ID: 11057857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
    Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
    J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.